ALMS vs ZBIO

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 01, 2026

ALMS

53.2
AI Score
VS
ZBIO Wins

ZBIO

58.7
AI Score

Investment Advisor Scores

ALMS

53score
Recommendation
HOLD

ZBIO

59score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric ALMS ZBIO Winner
Revenue 3.40M 1.00M ALMS
Net Income -235.27M -192.44M ZBIO
Net Margin -6913.7% -19244.3% ALMS
Operating Income -247.26M -185.01M ZBIO
ROE -52.0% -77.9% ALMS
ROA -42.0% -27.4% ZBIO
Total Assets 560.62M 701.69M ZBIO
Cash 63.71M 196.58M ZBIO
Current Ratio 6.74 9.93 ZBIO
Free Cash Flow -168.98M -132.44M ZBIO

Relative Price Performance (Last 90 Days)

ALMS 1M: -32.9% · 3M: -74.6% ZBIO 1M: -15.2% · 3M: +6.2%

Current Technical Phase

ALMS

Markdown
Sell / avoid

Price below a falling SMA50 (slope -30.8%), weak momentum, RSI 21

RSI (14): 21.3 · Price: $6.94

ZBIO

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 41

RSI (14): 40.8 · Price: $28.09

Fundamentals Snapshot

Metric ALMS ZBIO
Market Cap — —
Forward P/E -2.5 -6.0
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth -0.4% -1.0%
Gross Margin 1.0% -212.5%
Operating Margin -64.4% -77.7%
EPS -4.11 -9.63
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, ZBIO is currently the stronger investment candidate, winning 7 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.